A series of cyanide-bridged coordination networks has been prepared which contain [Ru(phen)(CN)4](2-) anions, Ln(III) cations, and additional oligopyridine ligands (1,10-phenanthroline, 2,2':6',2'''-terpyridine or 2,2'-bipyrimidine) which coordinate to the Ln(III) centres. Five structural types have been identified and examples of each type of structure are described: these are hexanuclear Ru4Ln2 clusters; two-dimensional Ru-Ln sheets with a honeycomb pattern of edge-linked Ru6Ln6 hexagons; one-dimensional chains consisting of two parallel cross-linked strands in a ladder-like arrangement; simple single-stranded chains of alternating Ru/Ln components; and a one-dimensional 'chain of squares' in which Ru2Ln2 squares are linked by bipyrimidine bridging ligands which connect to the Ln(III) corners of adjacent squares in the sequence. The 3MLCT luminescence characteristic of the [Ru(phen)(CN)4](2-) units is quenched in those networks containing Ln(III) which have low-lying near-infrared luminescent f-f states [Pr(III), Nd(III), Er(III), Yb(III)], with sensitised Ln(III)-based near-IR luminescence generated by d --> f energy-transfer. The rate of d --> f energy-transfer, and hence the degree of quenching of the 3MLCT luminescence from the [Ru(phen)(CN)4](2-) units, depends on the availability of f-f levels of an appropriate energy on the Ln(III) centre, with Nd(III) (with a high density of low-lying f-f states) being the most effective energy-acceptor and Yb(III) (with a single low-lying f-f state) being the least effective. Rates of d --> f energy-transfer to different Ln(III) centres could be determined from both the residual (partially quenched) lifetimes of the 3MLCT luminescence, and--in the case of the Yb(III) networks--by a rise-time for the sensitised near-IR luminescence. The presence of the 'blocking' polypyridyl ligands, which reduced the number of cyanide and water ligands that would otherwise coordinate to the Ln(III) centres, resulted in increases in the Ln(III)-based emission lifetimes compared to networks where these blocking ligands were not used.